J-C Piette
Overview
Explore the profile of J-C Piette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morel N, Le Guern V, Mouthon L, Piette J, Costedoat-Chalumeau N
Rev Med Interne
. 2022 Sep;
43(11):645-648.
PMID: 36088204
Cardiac involvement in systemic lupus (SL) and antiphospholipid syndrome (APS) can be due to variables and involve different presentations. Pericarditis is the most common lupus manifestation and occurs in 16%...
2.
Costedoat-Chalumeau N, Groh M, Piette J, Launay O
Rev Med Interne
. 2018 Jun;
40(6):347-350.
PMID: 29937299
No abstract available.
3.
Dion J, Leroux G, Mouthon L, Piette J, Costedoat-Chalumeau N
Rev Med Interne
. 2017 Sep;
39(6):400-407.
PMID: 28890262
Relapsing polychondritis (RP) is a rare condition characterized by recurrent inflammation of cartilaginous tissue and systemic manifestations. Data on pathophysiology are scarce and suggest an autoimmune mechanism. Recently, the possibility...
4.
Comarmond C, Jego P, Veyssier-Belot C, Marie I, Mekinian A, Elmaleh-Sachs A, et al.
Lupus
. 2017 Mar;
26(12):1291-1296.
PMID: 28355985
Objective To study the outcome of patients with antiphospholipid syndrome (APS) after oral anticoagulant treatment cessation. Methods We performed a retrospective study of patients with APS experiencing cessation of oral...
5.
Costedoat-Chalumeau N, Tamirou F, Le Guern V, Blanchet B, Deligny C, Piette J
Rev Med Interne
. 2016 Oct;
38(2):77-80.
PMID: 27745934
No abstract available.
6.
Jolly M, Galicier L, Aumaitre O, Frances C, Le Guern V, Liote F, et al.
Lupus
. 2016 Feb;
25(7):735-40.
PMID: 26876692
Objectives: Benefits of hydroxychloroquine (HCQ) use on physician reported outcomes are well documented in systemic lupus erythematosus (SLE). We assess for the first time the association and predictive value of...
7.
Morel N, Bonjour M, Le Guern V, Le Jeunne C, Mouthon L, Piette J, et al.
Lupus
. 2015 Jul;
24(14):1479-85.
PMID: 26163661
Objectives: Pericardial involvement is a frequent manifestation of systemic lupus erythematosus (SLE). Growing evidence suggests that colchicine may be useful for acute or recurrent pericarditis. We report for the first...
8.
Guettrot-Imbert G, Le Guern V, Morel N, Vauthier D, Tsatsaris V, Pannier E, et al.
Rev Med Interne
. 2015 Jan;
36(3):173-81.
PMID: 25579465
Pregnancy in systemic lupus erythematosus patients is a common situation that remains associated with higher maternal and fetal mortality/morbidity than in the general population. Complications include lupus flares, obstetrical complications...
9.
Orquevaux P, Masseau A, Le Guern V, Gayet V, Vauthier D, Boutin D, et al.
Rev Med Interne
. 2014 Sep;
36(3):154-8.
PMID: 25217451
Fertility is not impaired in systemic lupus erythematosus or antiphospholipid syndrome, but, similarly to the general population, these patients may undergo in vitro fertilization. This type of treatment increases the...
10.
Costedoat-Chalumeau N, Frances C, Pouchot J, Piette J
Rev Med Interne
. 2014 Jan;
35(8):487-90.
PMID: 24467799
No abstract available.